Benka Valerie A W, Levy Julie K
Project Manager, Alliance for Contraception in Cats & Dogs, Portland, Oregon, USA
Maddie's Shelter Medicine Program, College of Veterinary Medicine, University of Florida, USA.
J Feline Med Surg. 2015 Sep;17(9):758-65. doi: 10.1177/1098612X15594989.
GonaCon™ is the trade name of a GnRH-hemocyanin conjugate immunocontraceptive vaccine formulation shown to prevent reproduction and inhibit production of sex hormones in numerous mammalian species for extended durations. GonaCon is currently registered with the US Environmental Protection Agency (EPA) for contraception of female white-tailed deer, and GonaCon™-Equine for female wild horses and burros. Multiple formulations of this GnRH-hemocyanin conjugate immunocontraceptive vaccine have been developed at the National Wildlife Research Center in the United States.
Three studies employing an early generation vaccine formulation indicated its potential for multi-year contraception of female cats (median duration of effect in excess of 39.7 months). The contraceptive effect for male cats was less predictable and of shorter duration (median duration of effect 14 months). Since these initial feline studies there have been formulation composition changes, and further investigation of the safety, efficacy and duration of this contraceptive vaccine for cats is warranted.
Individual country regulations will determine if GonaCon could be registered for unowned, free-roaming and/or pet cats.
GonaCon™是一种促性腺激素释放激素-血蓝蛋白结合物免疫避孕疫苗制剂的商品名,已证明该制剂能在多种哺乳动物物种中长时间预防繁殖并抑制性激素的产生。GonaCon目前已在美国环境保护局(EPA)注册,用于雌性白尾鹿的避孕,而GonaCon™-Equine则用于雌性野马和野驴。美国国家野生动物研究中心已研发出这种促性腺激素释放激素-血蓝蛋白结合物免疫避孕疫苗的多种制剂。
三项采用早期疫苗制剂的研究表明,其对雌性猫具有多年避孕的潜力(效果的中位持续时间超过39.7个月)。对雄性猫的避孕效果较难预测且持续时间较短(效果的中位持续时间为14个月)。自这些最初的猫科动物研究以来,制剂成分已发生变化,因此有必要进一步研究这种避孕疫苗对猫的安全性、有效性和持续时间。
各国法规将决定GonaCon是否可注册用于无主、自由放养和/或宠物猫。